134 related articles for article (PubMed ID: 4784888)
1. Human serological response to louse-borne relapsing fever.
Dodge RW
Infect Immun; 1973 Dec; 8(6):891-5. PubMed ID: 4784888
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.
Porcella SF; Raffel SJ; Schrumpf ME; Schriefer ME; Dennis DT; Schwan TG
J Clin Microbiol; 2000 Oct; 38(10):3561-71. PubMed ID: 11015364
[TBL] [Abstract][Full Text] [Related]
3. Relapsing fever and its serological discrimination from Lyme borreliosis.
Rath PM; Rögler G; Schönberg A; Pohle HD; Fehrenbach FJ
Infection; 1992; 20(5):283-6. PubMed ID: 1385332
[TBL] [Abstract][Full Text] [Related]
4. Louse and tick borne relapsing fevers.
El-Bahnsawy MM; Labib NA; Abdel-Fattah MA; Ibrahim AM; Morsy TA
J Egypt Soc Parasitol; 2012 Dec; 42(3):625-38. PubMed ID: 23469636
[TBL] [Abstract][Full Text] [Related]
5. Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. I. Clinical course.
Judge DM; La Croix JT; Perine PL
Am J Trop Med Hyg; 1974 Sep; 23(5):957-61. PubMed ID: 4217570
[TBL] [Abstract][Full Text] [Related]
6. Lyme disease acquired in Israel: report of a case and studies of serological cross reactivity in relapsing fever.
Berger SA; Samish M; Kletter Y; Tinghitella T; Heering S; Edberg SC
Isr J Med Sci; 1993 Aug; 29(8):464-5. PubMed ID: 8407274
[No Abstract] [Full Text] [Related]
7. Serological evidence of louse-borne relapsing fever in northern Kenya.
Reyer F; Olesiuk M; Röttgerding F; Fingerle V; Adamu A; Waithiru D; Njeru J; Kraiczy P
Travel Med Infect Dis; 2024; 59():102714. PubMed ID: 38490400
[TBL] [Abstract][Full Text] [Related]
8. Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. III. Crisis following therapy.
Judge DM; La Croix JT; Perine PL
Am J Trop Med Hyg; 1974 Sep; 23(5):969-73. PubMed ID: 4217572
[TBL] [Abstract][Full Text] [Related]
9. Experimental louse-borne relapsing fever in the grivet monkey, Cercopithecus aethiops. II. Pathology.
Judge DM; La Croix JT; Perine PL
Am J Trop Med Hyg; 1974 Sep; 23(5):962-8. PubMed ID: 4217571
[TBL] [Abstract][Full Text] [Related]
10. Results of a 10-year survey of louse-borne relapsing fever in southern Ethiopia: a decline in endemicity.
Ramos JM; Malmierca E; Reyes F; Tesfamariam A
Ann Trop Med Parasitol; 2008 Jul; 102(5):467-9. PubMed ID: 18577339
[No Abstract] [Full Text] [Related]
11. The genome of Borrelia recurrentis, the agent of deadly louse-borne relapsing fever, is a degraded subset of tick-borne Borrelia duttonii.
Lescot M; Audic S; Robert C; Nguyen TT; Blanc G; Cutler SJ; Wincker P; Couloux A; Claverie JM; Raoult D; Drancourt M
PLoS Genet; 2008 Sep; 4(9):e1000185. PubMed ID: 18787695
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor, interleukin-6 and C-reactive protein in patients with louse-borne relapsing fever in Ethiopia.
Cuevas LE; Borgnolo G; Hailu B; Smith G; Almaviva M; Hart CA
Ann Trop Med Parasitol; 1995 Feb; 89(1):49-54. PubMed ID: 7741594
[TBL] [Abstract][Full Text] [Related]
13. GlpQ: an antigen for serological discrimination between relapsing fever and Lyme borreliosis.
Schwan TG; Schrumpf ME; Hinnebusch BJ; Anderson DE; Konkel ME
J Clin Microbiol; 1996 Oct; 34(10):2483-92. PubMed ID: 8880505
[TBL] [Abstract][Full Text] [Related]
14. Studies of the mechanism of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin.
Bryceson AD; Cooper KE; Warrell DA; Perine PL; Parry EH
Clin Sci; 1972 Sep; 43(3):343-54. PubMed ID: 5077513
[No Abstract] [Full Text] [Related]
15. Short report: Detection of borrelia (relapsing fever) in rural Ethiopia by means of the quantitative buffy coat technique.
Cobey FC; Goldbarg SH; Levine RA; Patton CL
Am J Trop Med Hyg; 2001 Aug; 65(2):164-5. PubMed ID: 11508395
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections.
Magnarelli LA; Anderson JF; Johnson RC
J Infect Dis; 1987 Jul; 156(1):183-8. PubMed ID: 3298452
[TBL] [Abstract][Full Text] [Related]
17. Louse-borne relapsing fever (Borrelia recurrentis infection).
Warrell DA
Epidemiol Infect; 2019 Jan; 147():e106. PubMed ID: 30869050
[TBL] [Abstract][Full Text] [Related]
18. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology and immunology of the Jarisch-Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin.
Warrell DA; Perine PL; Krause DW; Bing DH; MacDougal SJ
J Infect Dis; 1983 May; 147(5):898-909. PubMed ID: 6842024
[TBL] [Abstract][Full Text] [Related]
20. [STUDIES ON THE BEHAVIOR OF RELAPSING FEVER SPIROCHETES ESPECIALLY THE BORRELIA CROCIDURAE GROUP IN THE BODY LOUSE. 2].
HABERKORN A
Z Tropenmed Parasitol; 1963 Jul; 14():209-39. PubMed ID: 14047093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
